a few questions :
- when they say TT034 is first in human...what about the current HIV clinical trial underway? isnt that first in human?
- in the annual report they say that they are "earmarking additional funds to advance our Non Small Cell Lung Cancer" ..... Does this mean they have sufficient funds to carry out the ph1/2 clinical trials for this ?
Just a reminder to those who are pumping their fists as the BLT share price rises ...I've previously done the same and watched a significant stake in CBZ (now IVX) go from 17c to 79c..... Then very very quickly down to 3c on failed clinical trial results....
a few questions :- when they say TT034 is first in human...what...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)